COntinuous Glucose Monitoring in nEwborns of Mothers With Insulin-Treated Gestational Diabetes Mellitus

Starting soon · Not applicable

Conditions studied: Neonatal Hypoglycemia, Gestational Diabetes Mellitus (GDM)

In brief

The purpose of this study is to determine whether continuous glucose monitoring (CGM) improves the detection and management of neonatal hypoglycaemia in newborns of mothers with insulin-treated gestational diabetes.

Key facts

Study ID

NCT07462793

Run by

Institute of Mother and Child, Warsaw, Poland

People needed

120

Starts

2026-03-01

Expected to finish

2027-12-01

Last updated by the study team

2026-03-10

Who can join

Age: any. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Maternal age of 18 years or older
• Singleton pregnancy
• Insulin-treated gestational diabetes mellitus

You may not qualify if…

• Multifetal pregnancy
• Congenital malformations or metabolic defects in the newborn
• Preterm birth (defined as birth <37 weeks of gestation)
• Smoking during pregnancy
• Preeclampsia, fetal growth restriction
• Perinatal asphyxia
• Congenital infections in the newborn
• Adverse skin reactions (eczema, wounds) in the planned sensor insertion area

Where it is running

• Institute of Mother and Child — Warsaw, Poland

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.